Home > Insider Trading > Filing (0001123292-20-001299)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
882104	Pdl Biopharma Inc.	PDLI	Biological Products, (No Disgnostic Substances) (2836)	943023969

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
1029625	A Edward Mule	Two Greenwich Plaza, First Floor Greenwich CT 06830	No	No	Yes	No
1332784	L.p. Capital Point Silver	Two Greenwich Plaza, First Floor Greenwich CT 06830	No	No	Yes	No
1382617	J Robert O'shea	Two Greenwich Plaza, First Floor Greenwich CT 06830	No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-12-24	128,000	$2.65	16,954,460	No	4	P	Direct
Common Stock	Acquisiton	2020-12-28	235,000	$2.70	17,189,460	No	4	P	Direct
Common Stock	Acquisiton	2020-12-29	268,600	$2.69	17,458,060	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Silver Point Capital, L.P. ("Silver Point") or its wholly owned subsidiaries are the investment managers of Silver Point Capital Fund, L.P., Silver Point Capital Offshore Master Fund, L.P., Silver Point Distressed Opportunities Fund, L.P., Silver Point Distressed Opportunities Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners, L.P. and Silver Point Distressed Opportunity Institutional Partners Master Fund (Offshore), L.P. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all of the reported securities held by the Funds. Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Silver Point, Management and Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by the Funds except to the extent of their pecuniary interests.